1-4 of 4
Thomas A. Puchalski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy and Safety Of Siltuximab, An Anti-Interleukin-6 Monoclonal Antibody, In Patients With Multicentric Castleman’s Disease

Raymond S Wong, Corey Casper, Nikhil Munshi, Xiaoyan Ke, Alexander Fosså, David Simpson, Marcelo Capra, Ting Liu, MD, Ruey Kuen Hsieh, Yeow Tee Goh, Jun Zhu, Seok-Goo Cho, Hanyun Ren, James Cavet, Rajesh Bandekar, Margaret Rothman, Thomas A Puchalski, Shalini Chaturvedi, Helgi van de Velde, Jessica Vermeulen, Frits van Rhee
Journal: Blood
Blood (2013) 122 (21): 505.
https://doi.org/10.1182/blood.V122.21.505.505
Published: 2013
Journal Articles

QT Interval Effects and M-Protein Response in a Phase 1 Study of Siltuximab (Anti-IL-6 Monoclonal Antibody) in Patients with Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma.

Sheeba K. Thomas, MD, Alexander Suvorov, MD, Lucien Noens, MD, PhD, Oleg Rukavitsin, MD, Joseph Fay, MD, Ka Lung Wu, MD, PhD, Todd M Zimmerman, MD, Helgi van de Velde, MD, PhD, Rajesh Bandekar, PhD, Thomas A Puchalski, PharmD, Ming Qi, MD, PhD, Clarissa Uhlar, PhD, Olga S Samoilova, MD
Journal: Blood
Blood (2012) 120 (21): 2972.
https://doi.org/10.1182/blood.V120.21.2972.2972
Published: 2012
Journal Articles

Population Pharmacokinetic and Pharmacodynamic Modeling of an Anti–Interleukin-6 Chimeric Monoclonal Antibody, Siltuximab (CNTO 328), in Patients with B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease

Lanyi Xie, PhD, Lilian Y Li, PhD, Razelle Kurzrock, MD, Frits van Rhee, MD, PhD, Xiang Qin, MS, Manjula Reddy, MS, Ming Qi, MD, PhD, Hugh M Davis, PhD, Honghui Zhou, PhD, Thomas A Puchalski, PharmD
Journal: Blood
Blood (2012) 120 (21): 1365.
https://doi.org/10.1182/blood.V120.21.1365.1365
Published: 2012
Journal Articles

An Open, Phase I Study of Cediranib in Patients with Acute Myeloid Leukemia (AML).

Walter Fiedler, Rolf Mesters, Michael Heuser, Gerhard Ehninger, Oliver G. Ottman, Wolfgang E. Berdel, Ute Zirrgiebel, Jane Robertson, Thomas A. Puchalski, Sandra R. Brave, Juliane M. Jürgensmeier, Hubert Serve
Journal: Blood
Blood (2007) 110 (11): 895.
https://doi.org/10.1182/blood.V110.11.895.895
Published: 2007